Trials & R&D · first seen 3h ago, updated 3h ago
Directors’ Deals: AstraZeneca’s Soriot in a major show of faith
Share price is down after a series of disappointing drug trials
Summary from Financial Times - Pharmaceuticals.
Coverage 1 article · 1 outlet
-
Financial Times - PharmaceuticalsDirectors’ Deals: AstraZeneca’s Soriot in a major show of faith